Association between BDNF and clinical response in OCD
梅原, 英裕 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
沼田, 周助 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
木下, 誠 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
渡部, 真也 Tokushima University KAKEN研究者をさがす
Nakaaki, Shutaro Keio University
住谷, さつき Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
大森, 哲郎 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
Aim: Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family, and it promotes the development and function of dopaminergic and serotonergic neurons. The Met allele of the BDNF Val66Met polymorphism is associated with a decrease in activity-dependent secretion of BDNF compared with the Val allele, and a number of studies have provided evidence for the association between this polymorphism and obsessive-compulsive disorder (OCD). The purpose of this study was to investigate whether this functional variant of the BDNF gene is associated with OCD and treatment response in patients with OCD in the Japanese population.
Methods: We first performed a case–control association study between the BDNF Val66Met polymorphism and OCD (175 cases and 2,027 controls). Then, we examined an association between this polymorphism and treatment response in 96 patients with OCD.
Results: We found no significant association between the Met allele and OCD risk or between the Met allele and treatment responses to selective serotonin reuptake inhibitors or serotonin reuptake inhibitor with an atypical antipsychotic (P>0.05).
Conclusion: Our results suggest that the BDNF Val66Met polymorphism may not be associated as a risk factor for developing OCD or with therapeutic response in patients with OCD in the Japanese population.
Neuropsychiatric Disease and Treatment
Dove Medical Press
© 2016 Umehara et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
ndt_12_611.pdf 273 KB